Tumor cells preferentially meet their high cholesterol requirements by increasing endogenous cholesterol synthesis through upregulation of HMG-CoA reductase (3-hydroxy-3-methylglutaryl coenzyme A reductase) and increased expression of the LDL receptor [17, 18]. This evidence concerns the gene HMGCR and neoplasm.